Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-08-000195
Filing Date
2008-03-13
Accepted
2008-03-13 16:59:52
Documents
9
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a38914e10vk.htm 10-K 1080414
2 EXHIBIT 10.22 a38914exv10w22.htm EX-10.22 37690
3 EXHIBIT 10.23 a38914exv10w23.htm EX-10.23 37701
4 EXHIBIT 23.1 a38914exv23w1.htm EX-23.1 2236
5 EXHIBIT 31.1 a38914exv31w1.htm EX-31.1 6531
6 EXHIBIT 31.2 a38914exv31w2.htm EX-31.2 6855
7 EXHIBIT 32.1 a38914exv32w1.htm EX-32.1 5764
8 GRAPHIC a38914a3891401.gif GRAPHIC 4584
9 GRAPHIC a38914a3891402.gif GRAPHIC 8332
  Complete submission text file 0000936392-08-000195.txt   1196698
Mailing Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8584361400
CADENCE PHARMACEUTICALS INC (Filer) CIK: 0001333248 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33103 | Film No.: 08686742
SIC: 2834 Pharmaceutical Preparations